The Use of Exparel for Extended Pain Control in Minimally Invasive Cardiac Surgery

Trial Profile

The Use of Exparel for Extended Pain Control in Minimally Invasive Cardiac Surgery

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2016

At a glance

  • Drugs Bupivacaine (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jun 2016 Status changed from recruiting to discontinued.
    • 24 Sep 2015 Planned End Date changed from 1 Nov 2015 to 1 Aug 2017 according to the ClinicalTrials.gov record.
    • 24 Sep 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Aug 2016 according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top